Related Experiment Videos
Comparative Motor Pre-clinical Assessment in Parkinson's Disease Using Supervised Machine Learning Approaches
Erika Rovini1, Carlo Maremmani2, Alessandra Moschetti1
1The BioRobotics Institute, Scuola Superiore Sant'Anna, Viale Rinaldo Piaggio, 34, 56025, Pontedera, Italy.
Annals of Biomedical Engineering
|July 22, 2018
Summary
A wearable device, SensFoot V2, can detect Parkinson's disease (PD) and idiopathic hyposmia (IH) by analyzing lower limb movements. This technology aids in early PD detection and supports clinical assessment.
Area of Science:
- Neurology
- Biomedical Engineering
- Machine Learning
Background:
- Parkinson's disease (PD) significantly impacts quality of life, with diagnosis relying on motor symptoms.
- Non-motor symptoms, like idiopathic hyposmia (IH), are increasingly recognized for their association with PD risk.
- IH in healthy adults is linked to a higher likelihood of developing PD.
Purpose of the Study:
- To evaluate a wearable inertial device (SensFoot V2) for objective motor data acquisition.
- To differentiate between healthy individuals, individuals with IH, and PD patients using machine learning.
- To explore a non-invasive, two-step approach for early PD detection.
Main Methods:
- Collected motor data from 90 participants (30 healthy, 30 IH, 30 PD) using SensFoot V2 during MDS-UPDRS III lower limb tasks.
- Extracted significant, non-correlated motor parameters into a feature array.
- Applied three supervised machine learning algorithms for comparative classification analysis.
Main Results:
- The system achieved high accuracy (specificity and recall = 0.967) in distinguishing healthy individuals from PD patients.
- The machine learning model successfully identified IH as a distinct class with 0.78 accuracy.
- Identified key motor parameters that differentiate the three study groups.
Conclusions:
- The SensFoot V2 system shows potential as an objective tool to support clinical PD assessment.
- Combining IH identification with motor parameter analysis offers a promising non-invasive strategy for early PD detection.
- Wearable sensor technology can aid in the early identification of neurodegenerative conditions.